Drug intelligence / Profile preview

Viorra

Development stage: Preclinical
Lead developer: Easton Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

**Viorra** is an over-the-counter topical gel developed by Easton Pharmaceuticals for women's sexual health. It is designed to restore and improve vaginal moisture and elasticity, addressing symptoms of Female Sexual Arousal Disorder (FSAD) and potentially enhancing sexual desire and arousal. The product utilizes a transdermal delivery system with ingredients classified by the FDA as Generally Recognized as Safe (GRAS). Easton Pharmaceuticals, a specialty pharmaceutical company focused on topically-delivered therapeutics for sexual dysfunction, wound healing, and other conditions, planned its market launch in Mexico through a 2014 distribution deal with BMV Medica, subject to regulatory approvals and manufacturing partnerships.

Brand names: Viorra

Beyond the preview

Go deeper on Viorra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viorra.

Explore the full profile